![]() |
市場調查報告書
商品編碼
2148898
深部腦部刺激(DVT)市場規模、佔有率、成長率、全球產業分析、區域趨勢及2026-2034年預測。Deep Brain Stimulation Systems Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球深部腦部刺激(DSP)市場預計在2025年達到15.6億美元,並從2026年的17.4億美元成長至2034年的42億美元,預測期內年複合成長率(CAGR)為11.60%。北美將成為市場的主要驅動力,預計到2025年將佔46.44%的市場。該市場呈現強勁成長勢頭,主要得益於神經系統疾病盛行率的上升、老年人口的成長、神經調控技術的進步以及對微創手術需求的不斷成長。
深部腦部刺激(DBS)是一種外科治療方法,它使用植入式裝置向大腦特定區域傳遞電脈衝。 DBS系統通常由神經刺激設備、延長電纜和導線組成。這些系統廣泛用於治療帕金森氏症、肌張力不全症和原發性顫抖的相關症狀。人們對這種先進療法的認知不斷提高,以及DBS療法有助於緩解症狀和減少藥物依賴,正在推動市場擴張。
市場定義和範圍
深部腦部刺激(DVT)設備市場包括用於向特定腦區輸送可控電刺激的系統及相關組件,旨在治療神經系統疾病和運動障礙。該市場按產品類型、應用、最終用戶和地區進行分析。預計到2034年,醫療保健支出不斷成長、神經外科技術不斷進步以及對神經系統疾病治療技術的投資增加將創造更多商機。
市場動態
促進因素
對微創手術的需求日益成長
微創手術日益受到青睞是推動腦深部刺激(DBS)市場成長的主要動力。腦部深部刺激為帕金森氏症、肌張力不全症和原發性顫抖等疾病提供了一種標靶治療方法。與傳統手術相比,微創技術具有切口更小、疤痕更少、術後不適更輕、恢復更快等優勢。這些優勢促使患者和醫生對先進的神經外科手術越來越感興趣。
老年人口增加
人口老化加劇是另一個重要的成長要素。老年人更容易患上神經系統疾病,包括帕金森氏症和其他運動障礙。因此,全球老年人口的成長擴大了DBS治療的潛在患者群。此外,人們對神經系統疾病的認知不斷提高,診斷技術的進步也促使更多患者尋求專業治療。
趨勢
技術進步是塑造市場格局的關鍵趨勢。製造商正在開發先進的DBS系統,這些系統具有更精確的刺激控制、定向導線以及更個性化的治療功能。雙通道系統因其能夠實現雙側刺激並為醫生提供更大的治療柔軟性而備受關注。
阻礙因素
DBS系統、手術、專業醫療設施和術後監測的高成本可能會阻礙這種療法的廣泛應用,尤其是在開發中國家。此外,對訓練有素的神經外科醫生和專業治療中心的需求也可能限制醫療基礎設施薄弱地區獲得DBS療法的機會。
新冠疫情的影響
新冠疫情曾一度對市場造成衝擊,醫院優先處理急診手術,導致多例擇期神經外科手術延期。醫療設備供應鏈中斷和門診就診量下降也影響了手術量。然而,隨著醫療系統的復甦和擇期手術的恢復,市場趨於穩定。預計在預測期內,對神經專科醫療領域的投資增加將進一步推動市場發展。
依產品類型
市場細分將深部腦部刺激器(DBT)分為雙通道DBT和單通道DBT。預計到2025年,雙通道DBT將佔市場領先地位,這主要得益於技術進步以及能夠透過多根導線進行刺激的系統日益普及。定向刺激和個人化治療的進一步發展預計將進一步推動市場需求。
由於技術相對簡單且價格適中,單通道系統預計將保持穩定成長。在醫療成本是治療決策重要因素的發展中醫療市場,這些系統的應用將繼續至關重要。
用途別
從適應症來看,市場可細分為帕金森氏症、肌張力不全症、原發性顫抖和其他疾病。預計到2025年,帕金森氏症將成為最大的適應症細分市場,這主要得益於其龐大的患者群體以及對先進症狀管理療法的日益成長的需求。公眾意識的提高和醫療保健成本的上升預計將進一步推動DBS技術的應用。
預計隨著診斷技術的進步和對 DBS 治療的認知提高,DBS 在肌張力不全症和原發性顫抖治療中的應用將穩定成長。
最終用戶
依最終用戶分類,市場可分為醫院、專科診所和其他機構。醫院佔市場主導地位,因為DBS手術需要先進的基礎設施、訓練有素的專家、精密設備以及全面的術後護理。隨著神經專科治療中心的日益普及,專科診所也預計將隨之擴張。
北美洲
北美地區擁有先進的醫療基礎設施、活躍的研發活動以及眾多主要製造商,預計在2025年成為深部腦部刺激(DBS)市場的主要驅動力。北美市場規模預計在2025年達到3.234億美元。由於先進的DBS療法應用日益廣泛以及神經系統疾病患者數量的增加,該地區預計將持續成長。
亞太地區
預計到2034年,亞太地區市場將快速擴張。醫療保健支出增加、醫療基礎設施改善、人們對神經系統疾病的認知提高以及專科醫院數量的成長,都支撐了市場需求。日本、中國和印度預計仍將是重要的市場。
歐洲
在歐洲,由於神經系統疾病的高發生率和先進醫療設施的發展,預計市場將顯著成長。德國、英國和法國預計將為該地區的市場擴張做出重大貢獻。
本分析報告對深部腦部刺激(DVT)市場進行了全面評估,涵蓋市場規模、市場價值、市場區隔、區域趨勢、競爭格局、技術進步和行業趨勢。該研究按產品類型、應用和最終用戶類別對市場進行評估,並檢驗了北美、歐洲、亞太地區及其他地區的成長機會。此外,報告還重點關注影響市場的策略發展、產品發布、併購和技術創新。
單位價值(百萬美元)
The global deep brain stimulation devices market size was valued at USD 1.56 billion in 2025 and is projected to grow from USD 1.74 billion in 2026 to USD 4.20 billion by 2034, exhibiting a CAGR of 11.60% during the forecast period. North America dominated the market with a 46.44% market share in 2025. The market is witnessing strong growth due to the rising prevalence of neurological disorders, increasing geriatric population, technological advancements in neuromodulation, and growing demand for minimally invasive surgical procedures.
Deep brain stimulation (DBS) is a surgical treatment in which an implanted device delivers electrical impulses to targeted areas of the brain. A DBS system generally consists of a neurostimulator, extension, and lead. These systems are widely used to manage symptoms associated with Parkinson's disease, dystonia, and essential tremor. Increasing awareness regarding advanced treatment options and the ability of DBS therapy to reduce symptoms and medication dependence are supporting market expansion.
Market Definition and Scope
The deep brain stimulation devices market includes systems and associated components used to deliver controlled electrical stimulation to specific brain regions for managing neurological and movement disorders. The market is analyzed based on product type, application, end user, and region. Growing healthcare expenditure, expanding neurosurgical capabilities, and increasing investments in neurological treatment technologies are expected to create further opportunities through 2034.
Market Dynamics
Drivers
Rising Demand for Minimally Invasive Surgical Procedures
The increasing preference for minimally invasive procedures is a major factor supporting DBS market growth. Deep brain stimulation provides a targeted treatment approach for conditions such as Parkinson's disease, dystonia, and essential tremor. Compared with conventional surgical procedures, minimally invasive techniques can offer benefits such as smaller incisions, reduced scarring, lower postoperative discomfort, and faster recovery. These advantages are increasing patient and physician interest in advanced neurosurgical procedures.
Growing Geriatric Population
The expanding elderly population is another important growth driver. Older adults are more susceptible to neurological disorders, including Parkinson's disease and other movement-related conditions. The increasing number of elderly individuals worldwide is consequently expanding the potential patient pool for DBS therapy. Greater awareness of neurological diseases and improvements in diagnosis are also encouraging more patients to seek specialized treatment.
Trends
Technological advancement is an important trend shaping the market. Manufacturers are developing sophisticated DBS systems with improved stimulation control, directional leads, and more personalized treatment capabilities. Dual-channel systems are gaining attention because they can facilitate bilateral stimulation and provide physicians with greater flexibility in therapy delivery.
Restraints
The high cost associated with DBS systems, surgical procedures, specialized medical infrastructure, and postoperative monitoring can limit adoption, particularly in developing economies. In addition, the requirement for highly trained neurosurgeons and specialized treatment centers may restrict access to DBS therapy in regions with limited healthcare infrastructure.
Impact of COVID-19
The COVID-19 pandemic temporarily affected the market as hospitals prioritized emergency procedures and several elective neurological surgeries were postponed. Disruptions in medical-device supply chains and reduced hospital visits also affected procedure volumes. However, the recovery of healthcare systems and resumption of elective surgeries supported market stabilization. Increasing investment in specialized neurological care is expected to strengthen market development during the forecast period.
By Product Type
The market is segmented into dual-channel deep brain stimulators and single-channel deep brain stimulators. The dual-channel segment held the leading position in 2025, supported by technological advancements and increasing adoption of systems capable of providing stimulation through multiple leads. Improvements in directional stimulation and personalized therapy are expected to strengthen demand.
Single-channel systems are expected to witness steady growth because of their comparatively simpler technology and affordability. Their adoption may remain relevant in developing healthcare markets where cost considerations influence treatment decisions.
By Application
Based on application, the market is divided into Parkinson's disease, dystonia, essential tremor, and others. Parkinson's disease represented the leading application segment in 2025 because of the large patient population and increasing demand for advanced symptom-management therapies. Growing awareness and healthcare expenditure are expected to further support DBS adoption.
Dystonia and essential tremor are also expected to experience steady expansion as diagnosis improves and awareness of DBS treatment increases.
By End User
By end user, the market is categorized into hospitals, specialty clinics, and others. Hospitals accounted for the dominant position because DBS surgeries require advanced infrastructure, highly trained specialists, precision equipment, and comprehensive postoperative care. Specialty clinics are expected to expand as specialized neurological treatment centers become more prevalent.
North America
North America led the deep brain stimulation devices market in 2025, supported by advanced healthcare infrastructure, strong research and development activities, and the presence of major manufacturers. The North America market size reached USD 323.4 million in 2025. Increasing adoption of advanced DBS therapies and a growing neurological patient population are expected to sustain regional growth.
Asia Pacific
Asia Pacific is expected to witness rapid market expansion through 2034. Increasing healthcare expenditure, improving medical infrastructure, rising awareness of neurological disorders, and growing adoption of specialized hospitals are supporting demand. Japan, China, and India are expected to remain important markets.
Europe
Europe is projected to experience significant growth due to the prevalence of neurological disorders and the availability of advanced healthcare facilities. Germany, the U.K., and France are expected to contribute substantially to regional expansion.
Competitive Landscape
The market is relatively consolidated, with major companies focusing on technological development, product launches, strategic partnerships, and acquisitions. Key companies include Abbott, Medtronic, Boston Scientific Corporation, and Beijing PINS Medical Co., Ltd. Medtronic maintains a strong position through its neuromodulation portfolio and continued investment in DBS technologies. Boston Scientific has expanded its portfolio with systems incorporating directional lead technologies, while Abbott has strengthened its medical-device capabilities through strategic acquisitions.
Report Coverage
The deep brain stimulation devices market analysis provides a comprehensive assessment of market size, market value, segmentation, regional developments, competitive dynamics, technological advancements, and industry trends. The study evaluates the market across product type, application, and end-user categories while examining growth opportunities across North America, Europe, Asia Pacific, and other regions. It also highlights strategic developments, product launches, mergers and acquisitions, and technological innovations influencing the market.
Conclusion
The deep brain stimulation devices market is positioned for strong growth from 2025 through 2034, with market size expected to increase from USD 1.56 billion in 2025 to USD 4.20 billion by 2034. Rising neurological disorders, an aging population, growing preference for minimally invasive procedures, and advancements in DBS technology will remain key factors supporting market expansion. North America is expected to retain a strong position, while Asia Pacific offers significant future opportunities due to improving healthcare infrastructure and increasing awareness.
Unit Value (USD million)
Segmentation By Product Type
By Application
By End User
By Geography